BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 17002318)

  • 21. Increased susceptibility of vault poly(ADP-ribose) polymerase-deficient mice to carcinogen-induced tumorigenesis.
    Raval-Fernandes S; Kickhoefer VA; Kitchen C; Rome LH
    Cancer Res; 2005 Oct; 65(19):8846-52. PubMed ID: 16204055
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Solution structure of a two-repeat fragment of major vault protein.
    Kozlov G; Vavelyuk O; Minailiuc O; Banville D; Gehring K; Ekiel I
    J Mol Biol; 2006 Feb; 356(2):444-52. PubMed ID: 16373071
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vault nanocapsule dissociation into halves triggered at low pH.
    Goldsmith LE; Yu M; Rome LH; Monbouquette HG
    Biochemistry; 2007 Mar; 46(10):2865-75. PubMed ID: 17302392
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modulation of the Vault Protein-Protein Interaction for Tuning of Molecular Release.
    Yu K; Yau YH; Sinha A; Tan T; Kickhoefer VA; Rome LH; Lee H; Shochat SG; Lim S
    Sci Rep; 2017 Nov; 7(1):14816. PubMed ID: 29093465
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immobilization of recombinant vault nanoparticles on solid substrates.
    Xia Y; Ramgopal Y; Li H; Shang L; Srinivas P; Kickhoefer VA; Rome LH; Preiser PR; Boey F; Zhang H; Venkatraman SS
    ACS Nano; 2010 Mar; 4(3):1417-24. PubMed ID: 20146454
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structural stability of vault particles.
    Esfandiary R; Kickhoefer VA; Rome LH; Joshi SB; Middaugh CR
    J Pharm Sci; 2009 Apr; 98(4):1376-86. PubMed ID: 18683860
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Up-regulation of vaults may be necessary but not sufficient for multidrug resistance.
    Siva AC; Raval-Fernandes S; Stephen AG; LaFemina MJ; Scheper RJ; Kickhoefer VA; Rome LH
    Int J Cancer; 2001 Apr; 92(2):195-202. PubMed ID: 11291045
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multiple human vault RNAs. Expression and association with the vault complex.
    van Zon A; Mossink MH; Schoester M; Scheffer GL; Scheper RJ; Sonneveld P; Wiemer EA
    J Biol Chem; 2001 Oct; 276(40):37715-21. PubMed ID: 11479319
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assembly of vault-like particles in insect cells expressing only the major vault protein.
    Stephen AG; Raval-Fernandes S; Huynh T; Torres M; Kickhoefer VA; Rome LH
    J Biol Chem; 2001 Jun; 276(26):23217-20. PubMed ID: 11349122
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Beyond BLASTing: tertiary and quaternary structure analysis helps identify major vault proteins.
    Daly TK; Sutherland-Smith AJ; Penny D
    Genome Biol Evol; 2013; 5(1):217-32. PubMed ID: 23275487
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structural studies of large nucleoprotein particles, vaults.
    Tanaka H; Tsukihara T
    Proc Jpn Acad Ser B Phys Biol Sci; 2012; 88(8):416-33. PubMed ID: 23060231
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Crosstalk between Src and major vault protein in epidermal growth factor-dependent cell signalling.
    Kim E; Lee S; Mian MF; Yun SU; Song M; Yi KS; Ryu SH; Suh PG
    FEBS J; 2006 Feb; 273(4):793-804. PubMed ID: 16441665
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Draft crystal structure of the vault shell at 9-A resolution.
    Anderson DH; Kickhoefer VA; Sievers SA; Rome LH; Eisenberg D
    PLoS Biol; 2007 Nov; 5(11):e318. PubMed ID: 18044992
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis and assembly of human vault particles in yeast.
    Wang M; Kickhoefer VA; Rome LH; Foellmer OK; Mahendra S
    Biotechnol Bioeng; 2018 Dec; 115(12):2941-2950. PubMed ID: 30171681
    [TBL] [Abstract][Full Text] [Related]  

  • 35. vPARP Adjusts MVP Expression in Drug-resistant Cell Lines in Conjunction with MDR Proteins.
    Wojtowicz K; Januchowski R; Nowicki M; Zabel M
    Anticancer Res; 2017 Jun; 37(6):3015-3023. PubMed ID: 28551640
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vaults are dynamically unconstrained cytoplasmic nanoparticles capable of half vault exchange.
    Yang J; Kickhoefer VA; Ng BC; Gopal A; Bentolila LA; John S; Tolbert SH; Rome LH
    ACS Nano; 2010 Dec; 4(12):7229-40. PubMed ID: 21121616
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterisation of major vault protein during the life cycle of the human parasite Schistosoma mansoni.
    Reis EV; Pereira RV; Gomes M; Jannotti-Passos LK; Baba EH; Coelho PM; Mattos AC; Couto FF; Castro-Borges W; Guerra-Sá R
    Parasitol Int; 2014 Feb; 63(1):120-6. PubMed ID: 24148287
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MVP Expression Facilitates Tumor Cell Proliferation and Migration Supporting the Metastasis of Colorectal Cancer Cells.
    Pietras P; Leśniczak-Staszak M; Kasprzak A; Andrzejewska M; Jopek K; Sowiński M; Rucinski M; Lyons SM; Ivanov P; Szaflarski W
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34829999
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MVP and vaults: a role in the radiation response.
    Lara PC; Pruschy M; Zimmermann M; Henríquez-Hernández LA
    Radiat Oncol; 2011 Oct; 6():148. PubMed ID: 22040803
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanisms underlying lung resistance-related protein (LRP)-mediated doxorubicin resistance of non-small cell lung cancer cells.
    Chen YL; Yang TY; Wu CL; Chen KC; Hsu SL; Hsueh CM
    Chin J Physiol; 2016 Dec; 59(6):331-347. PubMed ID: 27817195
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.